Greater risk of bladder cancer in people with MS: study Ketogenic medium chain triglyceride drink improves cognition in mild cognitive impairmentAlready available in Europe, Nestlé aims to launch BrainXpert as a Natural Health Product in Canada in 2022. Epidural anesthesia during labour may increase risk of autism spectrum disorders in children Study finds 37% increased risk of autism spectrum disorders, with risk increasing with longer duration of epidural anesthesia. Emgality (galcanezumab) now indicated to reduce cluster headache frequency CGRP binding antibody is first drug approved by Health Canada to help prevent episodic cluster headaches What is the best treatment for medication overuse headache? Study examines three treatment strategies for medication overuse headache Suspect COVID-19 in patients presenting with neurological symptoms Neurological manifestations may include impaired consciousness, stroke, ataxia, seizure, taste/smell impairment, vision impairment, nerve pain and skeletal muscle pain Watch for drug interactions with cannabinoids in marijuana Select alternate drugs that do not interact with marijuana when clinically feasible New study examines tolerability of newer antiseizure medications Intolerable adverse effect rate has not improved over the past three decades despite increased use of second-generation antiseizure meds Managing sleep disorders during pregnancy and breastfeeding New guidance on management when nonpharmacologic interventions are ineffective MS drug fingolimod now contraindicated during pregnancy Pregnancy test now required before starting treatment and periodically during therapy First Previous 17 18 19 20 21 Next Last
